Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Total Liabilities (2021 - 2025)

Historic Total Liabilities for Prime Medicine (PRME) over the last 5 years, with Q3 2025 value amounting to $223.2 million.

  • Prime Medicine's Total Liabilities rose 5577.26% to $223.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $223.2 million, marking a year-over-year increase of 5577.26%. This contributed to the annual value of $144.4 million for FY2024, which is 13751.07% up from last year.
  • Latest data reveals that Prime Medicine reported Total Liabilities of $223.2 million as of Q3 2025, which was up 5577.26% from $218.1 million recorded in Q2 2025.
  • Prime Medicine's 5-year Total Liabilities high stood at $223.2 million for Q3 2025, and its period low was $38.1 million during Q1 2023.
  • Its 5-year average for Total Liabilities is $110.1 million, with a median of $67.6 million in 2024.
  • Per our database at Business Quant, Prime Medicine's Total Liabilities crashed by 7910.26% in 2023 and then soared by 24563.19% in 2025.
  • Prime Medicine's Total Liabilities (Quarter) stood at $62.3 million in 2021, then decreased by 29.3% to $44.0 million in 2022, then surged by 38.0% to $60.8 million in 2023, then skyrocketed by 137.51% to $144.4 million in 2024, then skyrocketed by 54.61% to $223.2 million in 2025.
  • Its last three reported values are $223.2 million in Q3 2025, $218.1 million for Q2 2025, and $221.2 million during Q1 2025.